$3 million grant to assist minorities with uncontrolled diabetes Researchers at the University of Illinois in Chicago’s Institute for Health Research and Plan and College of Medication have obtained a $3 million federal government grant to boost diabetes administration in minority patients. The grant will fund a five-year research to evaluate a new intervention made to improve lifestyle behaviors and medication compliance also to intensify therapy in minority individuals with uncontrolled type 2 diabetes. African-Americans and Latinos with diabetes often do not reach preferred blood sugar, blood pressure or cholesterol amounts, placing them at risky for complications or loss of life. We know there’s a breakdown in today’s health care system, said Lisa Sharp, assistant professor of medication and co-principal investigator of the study.We are privileged to work with the global innovator in X-ray therapy products, said Larry Findleton, president at AlderMed. We believe our provider improves the quality of care for the individual. At the same time, increasing the value of the dermatologist’s practice, by bringing an extremely affordable, mobile nonsurgical skin cancer treatment provider with their office. We are very impressed with the AlderMed SRTeam approach, says Adrian Treverton, Product sales Director of Xstrahl. Including the oncologist, medical physicist and radiation therapist as part of the remedy approach shares our eyesight of effective delivery of superficial radiation therapy.